TY - JOUR
T1 - Expression of immunoreactivity to neurokinin-1 receptor by subsets of cranial parasympathetic neurons
T2 - Correlation with neuropeptides, nitric oxide synthase, and pathways
AU - Shimizu, T.
AU - Morris, J. L.
AU - Gibbins, I. L.
N1 - Funding Information:
This study was funded by grants from the National Health & Medical Research Council of Australia (NHMRC). Dr. Shimizu was supported by a scholarship from the Japan Research Foundation for Clinical Pharmacology. Associate Professor Morris is a Principal Research Fellow of the NHMRC. We are grateful to Sue Matthew and Pat Vilimas for excellent assistance and to Dr. Ryuichi Shige-moto for the generous gift of the NK1 receptor antibody.
PY - 2001
Y1 - 2001
N2 - We examined the patterns of coexistence of immunoreactivity to the neurokinin-1 (NK1) tachykinin receptor, nitric oxide synthase, and neuropeptides in the sphenopalatine and otic ganglia of guinea pigs using a combination of multiple-labeling immunohistochemistry and pathway tracing in vitro. Most neurons had immunoreactivity to vasoactive intestinal peptide (85-96%) and neuropeptide Y (60%). Subpopulations of vasoactive intestinal peptide-immunoreactive neurons also had immunoreactivity to nitric oxide synthase (37-48%) or enkephalin (25-35%), but these formed mutually exclusive populations. Almost all neurons expressing NK1 receptor immunoreactivity contained immunoreactivity to enkephalin, vasoactive intestinal peptide, and neuropeptide Y, but not nitric oxide synthase. Using a combination of retrograde axonal tracing and axonal crushing, we found that most neurons with immunoreactivity to nitric oxide synthase projected along the nasopalatine and moidal nerves to the nasal mucosa. In contrast, most neurons with immunoreactivity to enkephalin followed the zygomatic nerve to the facial skin and lacrimal gland. Based on their peptide content, we conclude that the neurons with immunoreactivity to enkephalin and NK1 receptor projected selectively to the skin. In both the sphenopalatine and the otic ganglia, about half of the neurons with NK1 receptor immunoreactivity were surrounded by varicose nerve fibers with substance P immunoreactivity. Many of these fibers are likely to have originated in the trigeminal ganglion. Taken together, these observations establish a strong anatomical basis for a range of interactions between trigeminal and cranial parasympathetic pathways that may underlie pathophysiological conditions such as trigeminal neuralgia.
AB - We examined the patterns of coexistence of immunoreactivity to the neurokinin-1 (NK1) tachykinin receptor, nitric oxide synthase, and neuropeptides in the sphenopalatine and otic ganglia of guinea pigs using a combination of multiple-labeling immunohistochemistry and pathway tracing in vitro. Most neurons had immunoreactivity to vasoactive intestinal peptide (85-96%) and neuropeptide Y (60%). Subpopulations of vasoactive intestinal peptide-immunoreactive neurons also had immunoreactivity to nitric oxide synthase (37-48%) or enkephalin (25-35%), but these formed mutually exclusive populations. Almost all neurons expressing NK1 receptor immunoreactivity contained immunoreactivity to enkephalin, vasoactive intestinal peptide, and neuropeptide Y, but not nitric oxide synthase. Using a combination of retrograde axonal tracing and axonal crushing, we found that most neurons with immunoreactivity to nitric oxide synthase projected along the nasopalatine and moidal nerves to the nasal mucosa. In contrast, most neurons with immunoreactivity to enkephalin followed the zygomatic nerve to the facial skin and lacrimal gland. Based on their peptide content, we conclude that the neurons with immunoreactivity to enkephalin and NK1 receptor projected selectively to the skin. In both the sphenopalatine and the otic ganglia, about half of the neurons with NK1 receptor immunoreactivity were surrounded by varicose nerve fibers with substance P immunoreactivity. Many of these fibers are likely to have originated in the trigeminal ganglion. Taken together, these observations establish a strong anatomical basis for a range of interactions between trigeminal and cranial parasympathetic pathways that may underlie pathophysiological conditions such as trigeminal neuralgia.
KW - Enkephalin
KW - Neurokinin-1 receptor
KW - Nitric oxide synthase
KW - Otic ganglion
KW - Parasympathetic
KW - Sphenopalatine (pterygopalatine)ganglion
KW - Substance P
KW - Trigeminal neuralgia
UR - http://www.scopus.com/inward/record.url?scp=0035690615&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035690615&partnerID=8YFLogxK
U2 - 10.1006/exnr.2001.7799
DO - 10.1006/exnr.2001.7799
M3 - Article
C2 - 11716554
AN - SCOPUS:0035690615
SN - 0014-4886
VL - 172
SP - 293
EP - 306
JO - Neurodegeneration
JF - Neurodegeneration
IS - 2
ER -